Discover and read the best of Twitter Threads about #AccessToMedicines
Most recents (2)
THREAD: MSF has experienced first-hand positive and negative impacts of voluntary licenses on access to the medicines we provide to people in our care and beyond.
Here are some things you should know about voluntary licenses & access to medicines 👇
Here are some things you should know about voluntary licenses & access to medicines 👇
Did you know that pharma companies often restrict to where and to whom a generic drug can be sold?
This happens via private contracts, meaning that people are denied #AccessToMedicines due to geographic limitations decided in secret agreements.😤
🔽
bit.ly/31xgvu3
This happens via private contracts, meaning that people are denied #AccessToMedicines due to geographic limitations decided in secret agreements.😤
🔽
bit.ly/31xgvu3
Did you know that during public health emergencies, governments have legal ways to override patents and produce or import any generic drug without the consent of the pharma company that owns the patent?
It’s simple: put lives over patents.
bit.ly/35tpgpY
It’s simple: put lives over patents.
bit.ly/35tpgpY
Interesting proposal that begs the question of inadequacy of territorially applied compulsory licenses & the cumbersome, narrow solution of such licenses for export. #AccessToMedicines #Patents Two problems remain
First, how do you price a patent that covers a pandemic drug? Will humanitarian needs drive up or down reasonable remuneration. There will be lessons there for developing countries looking to apply TRIPS flexibilities in the context of public health needs.
Secondly purchasing the patent to 'maintain R&D incentives for the pharmaceutical sector' assumes our incentives are fit for purpose. Instead of condoning monopoly pricing that has become the norm here,
